Postmenopausal hormone therapy and venous thromboembolism

Thrombosis Research

Volumn 127, Issue SUPPL. 3, 2011, Pages

  Olié, Valérie ^a,b   Canonico, Marianne ^a,b   Scarabin, Pierre Yves ^a,b  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Dose; Hormone therapy; Progestogens; Recurrent venous thromboembolism; Transdermal estrogens; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ESTROGEN; GESTAGEN; PROGESTERONE; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ADJUVANT THERAPY; ARTICLE; BLOOD CLOTTING; BODY MASS; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG SAFETY; ESTROGEN THERAPY; FIBRINOLYSIS; FIRST PASS EFFECT; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; META ANALYSIS (TOPIC); MORBIDITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REACTOR CASCADE; RECURRENCE RISK; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; PROGESTERONE; PROGESTINS; VENOUS THROMBOEMBOLISM;

EID: 79251518062     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(11)70008-1     Document Type: Article

References (38)

1. JE Rossouw, GL Anderson, RL Prentice, AZ LaCroix, C Kooperberg, ML Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 Jul 17 321 333
2. M Cushman, LH Kuller, R Prentice, RJ Rodabough, BM Psaty, RS Stafford Estrogen plus progestin and risk of venous thrombosis JAMA 292 13 2004 Oct 6 1573 1580
3. JD Curb, RL Prentice, PF Bray, RD Langer, L Van Horn, VM Barnabei Venous thrombosis and conjugated equine estrogen in women without a uterus Arch Intern Med 166 7 2006 Apr 10 772 780
4. HD Nelson Menopause Lancet 371 9614 2008 Mar 1 760 770
5. V Olie, M Canonico, PY Scarabin Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women Curr Opin Hematol 17 5 2010 Sep 457 463
6. PY Scarabin, E Oger, G Plu-Bureau Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk Lancet 362 9382 2003 Aug 9 428 432
7. M Canonico, G Plu-Bureau, GD Lowe, PY Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ Clin Res 336 7655 2008 May 31 1227 1231
8. C Renoux, S Dell'aniello, S Suissa Hormone replacement therapy and the risk of venous thromboembolism: population-based study J Thromb Haemost 8 5 2010 May 979 986
9. Olie V, Plu-Bureau G., Conard J., Horellou MH., Canonico M., Scarabin PY. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause; in press.
10. M Canonico, E Oger, G Plu-Bureau, J Conard, G Meyer, H Levesque Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 7 2007 Feb 20 840 845
11. M Canonico, A Fournier, L Carcaillon, V Olie, G Plu-Bureau, E Oger Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study Arterioscler Thromb Vasc Biol 30 2 2010 Feb 340 345
12. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center N Engl J Med 290 l 1974 Jan 3 15 19
13. H Jick, S Jick, MW Myers, C Vasilakis Risk of acute myocardial infarction and low-dose combined oral contraceptives Lancet 347 9001 1996 Mar 2 627 628
14. E Daly, MP Vessey, MM Hawkins, JL Carson, P Gough, S Marsh Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 9033 1996 Oct 12 977 980
15. S Perez Gutthann, LA Garcia Rodriguez, J Castellsague, A Duque Oliart Hormone replacement therapy and risk of venous thromboembolism: population based case-control study BMJ Clin Res 314 7083 1997 Mar 15 796 800
16. NL Smith, SR Heckbert, RN Lemaitre, AP Reiner, T Lumley, NS Weiss Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis JAMA 292 13 2004 Oct 6 1581 1587
17. JD Douketis, JA Julian, C Kearon, DR Anderson, MA Crowther, SM Bates Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study J Thromb Haemost 3 5 2005 May 943 948
18. F Grodstein, MJ Stampfer, SZ Goldhaber, JE Manson, GA Colditz, FE Speizer Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 9033 1996 Oct 12 983 987
19. C Schneider, SS Jick, CR Meier Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations Climacteric 12 5 2009 Oct 445 453
20. T Ohira, AR Folsom, M Cushman, RH White, PJ Hannan, WD Rosamond Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology Br J Haematol 149 4 2010 May 606 612
21. E Hoibraaten, E Qyigstad, H Arnesen, S Larsen, E Wickstrom, PM Sandset Increased risk of recurrent venous thromboembolism during hormone replacement therapy - results of the randomized, double-blind, placebocontrolled estrogen in venous thromboembolism trial (EVTET) Thromb Haemost 84 6 2000 Dec 961 967
22. C Straczek, E Oger, MB Yon de Jonage-Canonico, G Plu-Bureau, J Conard, G Meyer Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration Circulation 112 22 2005 Nov 29 3495 3500
23. M Canonico, E Oger, J Conard, G Meyer, H Levesque, N Trillot Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study J Thromb Haemost 4 6 2006 Jun 1259 1265
24. PY Scarabin, M Alhenc-Gelas, G Plu-Bureau, P Taisne, R Agher, M Aiach Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial Arterioscler Thromb Vasc Biol 17 ll 1997 Nov 3071 3078
25. M Hemelaar, MJ van der Mooren, M Rad, C Kluft, P Kenemans Effects of nonoral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review Fertil Steril 90 3 2008 Sep 642 672
26. MS Post, M Christella, LG Thomassen, MJ van der Mooren, WM van Baal, J Rosing Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebocontrolled study in postmenopausal women Arterioscler Thromb Vase Biol 23 6 2003 Jun 1 1116 1121
27. E Oger, M Alhenc-Gelas, K Lacut, MT Blouch, N Roudaut, V Kerlan Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial Arterioscler Thromb Vasc Biol 23 9 2003 Sep 1 1671 1676
28. PM Sandset, E Hoibraaten, AL Eilertsen, A Dahm Mechanisms of thrombosis related to hormone therapy Thromb Res 123 Suppl 2 2009 S70 S73
29. MC de Visser, A van Hylckama Vlieg, G Tans, J Rosing, AE Dahm, PM Sandset Determinants of the APTT- and ETP-based APC sensitivity tests J Thromb Haemost 3 7 2005 Jul 1488 1494
30. J Rosing, S Middeldorp, J Curvers, M Christella, LG Thomassen, GA Nicolaes Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study Lancet 354 9195 1999 Dec 1l 2036 2040
31. HC Hemker, P Giesen, R Al Dieri, V Regnault, E de Smedt, R Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 1 2003 4 15
32. PY Scarabin, M Canonico, L Carcaillon, O Rouaud, K Ritchie, JF Dartigues Influence of hormone therapy on thrombin generation among postmenopausal women: importance of the route of estrogen administration Arterioscler Thromb Vasc Biol 2010 abstract.
33. CN Bagot, MS Marsh, M Whitehead, R Sherwood, L Roberts, RK Patel The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy J Thromb Haemost 8 8 2010 Aug 1736 1744
34. GL Anderson, M Limacher, AR Assaf, T Bassford, SA Beresford, H Black Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 14 2004 Apr 14 1701 1712
35. MR Vickers, AH MacLennan, B Lawton, D Ford, J Martin, SK Meredith Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women BMJ Clin Res 335 7613 2007 Aug 4 239
36. M Canonico, M Alhenc-Gelas, G Plu-Bureau, V Olie, PY Scarabin Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen Menopause 17 6 2010 Nov-Dec 1122 1127
37. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society Menopause 17 2 2010 Mar 242 255
38. KA Martin, JE Manson Approach to the patient with menopausal symptoms J Clinical Endocrinol Metab 93 12 2008 Dec 4567 4575